Summary of the 29th meeting of the Gastrointestinal Drugs Advisory Committee, Food and Drug Administration--June 10, 1985.
D000022:Abortion, Spontaneous / Q000139:chemically induced; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002927:Cimetidine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D016595:Misoprostol; D010146:Pain / Q000188:drug therapy; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D011459:Prostaglandins E, Synthetic; D016595:Misoprostol; D002927:Cimetidine